Your Article Summary
See Latest ArticlesEffect of Calcipotriol on Etanercept Partial Responder Psoriasis Vulgaris and Psoriatic Arthritis Patients
Acta Dermato-Venereologica, 06/24/09
Campione E et al. - This is the first report about the controlled combination of topical calcipotriol and etanercept in a large group of psoriatic patients. The efficacy and cost-effectiveness of the combined treatment is evidenced by the good response shown at week 24 by a group of etanercept low-responder patients using drugs sparingly and limiting likely toxicity.
Related Articles
Optical coherence tomography imaging of psoriasis vulgaris: correlation with histology and disease severity
Archives of Dermatological Research, 11/17/09
Relevance Score: 67%
Urinary biomarker of oxidative stress in patients with psoriasis vulgaris and atopic dermatitis
Journal of the European Academy of Dermatology and Venereology, 11/24/09
Relevance Score: 66%
Membranoproliferative Glomerulonephritis Associated with Psoriasis Vulgaris
Renal Failure, 11/30/09
Relevance Score: 65%
FDA Approves New Drug to Treat Psoriasis
Internet Source, 11/02/09
Relevance Score: 46%
Methotrexate versus traditional Chinese medicine in psoriasis: a randomized, placebo-controlled trial to determine efficacy, safety and quality of life
Clinical and Experimental Dermatology, 11/25/09
Relevance Score: 45%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Low-dose methotrexate treatment for moderate-to-severe atopic dermatitis in adults
Journal of the European Academy of Dermatology and Venereology, 12/17/09
Multiple epidermal cysts occcurring in a tattoo
Singapore Medical Journal, 12/17/09
Efficacy and safety of linezolid in methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infection: a meta-analysis
Current Medical Research and Opinion, 12/17/09
Today in Psoriasis...keeping you current
Receive free subspecialty "5-minute updates" via email
Development and validation of nail psoriasis quality of life scale (NPQ10)
Journal of the European Academy of Dermatology and Venereology, 12/16/09
Efficacy and Safety of Efalizumab in Patients with Moderate-to-Severe Plaque Psoriasis Resistant to Previous Anti-Psoriatic Treatment: Results of a Multicentre, Open-label, Phase IIIb/IV Trial
Archives of Drug Information, 12/08/09
Analysis of psoriatic patients registered in Asahikawa Medical College Hospital from 1983 to 2007
Journal of Dermatology, 12/08/09